Delivery Order SPE2DB20D3103-SPE2DB25FP9E9
Award Date 8/18/25
Potential Completion Date 9/9/25
Potential Value $43K
Federal Agency
Awardee
Ultimate Awardee
Not listed PSC Category
Federal Contract Vehicle
- Not listed
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The Defense Logistics Agency awarded a delivery order valued at $7,110.80 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials. This is a firm fixed-price, competitively awarded contract with no set-aside designation, with a completion date of September 9, 2025. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform this work at its corporate office location in Conshohocken, PA 19428. This delivery order is...
- AmerisourceBergen Drug Corp has been awarded a delivery order valued at $17,777.00 for 100 mg vials of Enhertu, a oncology therapeutic agent used in cancer treatment. This firm fixed-price, competitively awarded contract was issued by the Defense Logistics Agency Medical Supply Chain on August 14, 2025, with a completion date of September 5, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order represents a child...
- The Defense Logistics Agency awarded a $17,777 firm fixed price delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a HER2-directed antibody-drug conjugate used in oncology treatment. This non-set-aside competitive award, issued on July 25, 2025, is scheduled for completion by August 15, 2025, with performance taking place at AmerisourceBergen's Conshohocken, Pennsylvania facility. The delivery order represents a child contract under AmerisourceBergen's larger...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 22, 2025, for the supply of Enhertu 100 mg vials, a specialty pharmaceutical product used in oncology treatment. This firm fixed-price delivery order, valued at $10,666.20, is set to be completed by August 12, 2025, and will be performed at AmerisourceBergen's facility in Conshohocken, Pennsylvania. The contract represents a non-competitive delivery order issued under a larger indefinite delivery...
- The Defense Logistics Agency awarded a delivery order valued at $35,554.00 to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials, with an ultimate completion date of August 20, 2025. This competitively awarded, firm fixed-price contract utilizes no set-aside designation and specifies Conshohocken, Pennsylvania as the place of performance, which aligns with the contractor's corporate headquarters location. The delivery order is issued under AmerisourceBergen Drug Corp's larger...
- This delivery order, valued at $17,777, was awarded on July 22, 2025, to AmerisourceBergen Drug Corp for the supply of Enhertu 100 mg vials under a firm fixed-price arrangement. The contract is a non-set-aside award issued by the Medical Supply Chain, a Defense-focused federal agency, with a completion deadline of August 12, 2025. AmerisourceBergen, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 28, 2025, for the supply of 100 mg vials of Enhertu, a prescription oncology medication, with a ceiling value of $7,110.80. This firm fixed-price contract, which is not set-aside, has an ultimate completion date of August 18, 2025, and represents a child award under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 through...
- The Defense Logistics Agency awarded a delivery order valued at $17,777.00 to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a cancer therapeutic agent. This firm fixed price delivery order was competitively awarded without set-aside designation and is scheduled for completion by September 5, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company maintains its primary operations as a leading...
- Amerisourcebergen Drug Corp has received a firm fixed price delivery order from the Defense Logistics Agency Troop Support Medical for $14,505.93 to supply 100 mg vials of Enhertu. Performance will take place at Amerisourcebergen's facility in Conshohocken, Pennsylvania, with completion by November 28, 2023. This order was awarded against an indefinite delivery contract held by Amerisourcebergen with no set-aside designation specified. As a leading pharmaceutical distributor, Amerisourcebergen...
- The Defense Logistics Agency awarded a $10,666.20 delivery order to AmerisourceBergen Drug Corp for 100 mg vials of Enhertu, a prescription oncology medication used in cancer treatment. This firm fixed-price delivery order, issued on August 13, 2025, represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), valued at $999,999,999 through December 2026. The award was made through open competition with no set-aside...